Tumor Ablation Market Anticipated to Reach USD 2.30 Billion at a CAGR of 11.2% By 2026

Originally published on Health - Trend Magazine

Reports And Data

Tumor Ablation Market – High target disease prevalence, product launches, increasing strategic developments are key factors Drives Revenue Growth

NEW YORK CITY, NEW YORK, UNITED STATES, June 24, 2022 /EINPresswire.com/ — According to the current analysis of Reports and Data, the global Tumor Ablation market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %. The study covers Tumor Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor. Tumor ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia. Ablation is preferred over other methods of treatment such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay. The increasing economic impact of cancer which shows increased prevalence of cancer among the population which increases the demand for the cancer treatment. In the year 2016 US the annual cost for cancer was USD 80.2 billion of which 38% cost was estimated due to inpatient hospital stays which can be reduced to quite good extent as the tumor ablation demands short duration of hospital stay.

Rising prevalence of target diseases such as lung and liver cancer due to various reasons such as unhealthy living styles and hereditary factor, unmet needs of patients demanding drug developments, increased focus of pharmaceutical companies on development of easier methods of testing and monitoring, entry of various players, private investment and governmental funding, and favorable regulatory scenario, increasing demand for less to no pain treatments are some of the key factors driving the market growth in the industry. New technological innovation of surgical technology taking place such as development in existing radio frequency ablation system now with multi electrode radio frequency system which produces radiofrequency using multi channels.

Access Free sample PDF Copy of the Report @

Key participants include: Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.

Further key findings from the report suggest

Tumor Ablation market is growing at a CAGR of 12% in Asia Pacific followed by North America and Europe, with 0% and 10.9% CAGR, respectively. High cancer prevalence across the globe is the major factor driving the market during the forecast period across all regions.
The Radiofrequency Ablation segment dominates the market with a 25% market share. It is also estimated to grow at a CAGR of 10.3% as it is more preferably used for localized tumor ablation surgery especially for malignant liver cancer as it do not require longer period of hospital stay for the pre surgery observations
The microwave ablation segment is forecasted to be the fastest growing market segment, estimated to hold a 12.1% CAGR. Microwave ablation expects less risk and shorter duration of the hospital stay. Microwave ablation can perform for the treatment of multiple tumors simultaneously.

Gain a better understanding of what more we have to offer:-

Based on end use, the liver cancer segment dominates the market holding a 23.0% market share and is estimated to grow at a 12.1% CAGR. For the year 2018 American Cancer Society forecasted the liver cancer cases in the US might be approximately 42,220 and is expected to keep on increasing. It is the only cancer in the US which is continuously increasing
Asia Pacific is expected to account for the 26.6% of the global Tumor Ablation market. Developing nations such China, and India are likely to witness high growth due to uncontrolled population growth, more aged population, adherence to unhealthy habits and diet and infinite pollution growth
Slow rate of commercialization, high costs involved in research and development, reluctance toward the adoption of new treatment practices and government regulations that require long certification and approval cycles are likely to hamper growth of the market

To know more about the report:

Segments covered in the report:

Treatment Type Outlook (Revenue, USD Million; 2016-2026)

Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation

Technology Type Outlook (Revenue, USD Million; 2016-2026)

Radiofrequency Ablation
Cryoablation
Microwave Ablation
Irreversible Electroporation
Other Ablation Technologies

Application Type Outlook (Revenue, USD Million; 2016-2026)

Liver Cancer
Lung Cancer
Breast cancer
Prostate Cancer
Other Cancer

Ask for Customize Research Report @

Regional Outlook (Revenue, USD Billion; 2018-2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Explore More Related Reports:

Microcapsule Market:

Surgical Forceps Market:

Skin Cancer Market:

Window Tint Market:

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Tushar Rajput
Reports and Data
+ 12127101370
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn



Article originally published at https://www.einpresswire.com/article/578292983/tumor-ablation-market-anticipated-to-reach-usd-2-30-billion-at-a-cagr-of-11-2-by-2026-reports-and-data

Health Women's Health

Ontario Votes 2022: election night | CBC News special

CBC News provides all of the election results and expert analysis as Ontarians head to the polls. To read more: »»» Subscribe to CBC News to watch more videos: Connect with CBC News Online: For breaking news, video, audio and in-depth coverage: Find CBC News on Facebook: Follow CBC News on Twitter: For breaking news […]

Read More
Health Women's Health

Jumpstart Foundry Announces New Managing Director, Haley Zapolski

Haley “Zap” Zapolski Nashville-based healthcare innovation fund prepares for a bright future with new MD NASHVILLE, TENNESSEE, UNITED STATES, August 5, 2022 /EINPresswire.com/ — Pre-seed healthcare innovation fund Jumpstart Foundry (JSF) announces today the appointment of its new Managing Director, Haley “Zap” Zapolski. “The addition of Haley as the Jumpstart Foundry MD is an exciting […]

Read More
Health Women's Health

How to EASILY Kick Start A Healthy Lifestyle FAST!! (For FREE!!)

Animation by Health chronicle explaining how you can start a healthy lifestyle. Health Chronicle releases a health educational video a week. Subscribe here – goo.gl/aCbMww Support us on Patreon Please Subscribe to Health Chronicle. Like and comment on this video. Share this video with your family and friends. Visit for more information Or follow us […]

Read More

This news story originally appeared at Health - Trend Magazine on 1 July 2022

Content originally appeared on NuWomanMagazine.com